MoonLake Immunotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade MoonLake Immunotherapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MLTX

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. 

CEO
Jorge Santos da Silva
CEOJorge Santos da Silva
Employees
100
Employees100
Headquarters
Zug, Zug
HeadquartersZug, Zug
Founded
2021
Founded2021
Employees
100
Employees100

MLTX Key Statistics

Market cap
3.14B
Market cap3.14B
Price-Earnings ratio
-21.20
Price-Earnings ratio-21.20
Dividend yield
—
Dividend yield—
Average volume
881.99K
Average volume881.99K
High today
—
High today—
Low today
—
Low today—
Open price
$50.31
Open price$50.31
Volume
0.00
Volume0.00
52 Week high
$58.26
52 Week high$58.26
52 Week low
$31.42
52 Week low$31.42

Analyst ratings

100%

of 17 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own MLTX. This list is generated using Robinhood data, and it’s not a recommendation.
Eli Lilly
Taiwan Semiconductor Manu…
Alphabet Class A
Broadcom
AMD
Robinhood Markets
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.